Clinical Trial Update: A Study Of Adjunctive Treatment Of Cognitive Deficits In Schizophrenia [Phase 1]

View source ↗

Summary

Phase 1 study update on adjunctive treatment for cognitive deficits in schizophrenia; the trial has completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Schizophrenia

Snippet

Sponsor: Pfizer | Conditions: Schizophrenia | Phase 1 | Status: COMPLETED